Disc Medicine, Inc. (NASDAQ:IRON) Sees Large Growth in Short Interest

NodeGuardian · 2026-03-16T12:09:04+00:00

Disc Medicine, Inc. saw a 25.1% rise in short interest in February, indicating increased bearish sentiment. Analysts rate it as a "Moderate Buy" with a target of $104.80, while insiders recently sold shares reducing ownership.

NodeGuardian

2026-03-16 12:09:04

Abstract generation in progress

Disc Medicine, Inc. (NASDAQ:IRON) experienced a 25.1% increase in short interest during February, reaching 4,269,919 shares, which signals elevated bearish sentiment for the stock. Despite this, analysts maintain a “Moderate Buy” rating with a consensus price target of $104.80, significantly above its current trading price of $60.04. Over the last quarter, insiders sold 206,985 shares worth $17.5M, reducing insider ownership, while institutional investors hold 83.7% of the company’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.